Clinical Trials Logo
  1. Home
  2. Adverse Reaction to Drug
  3. NCT01830257

Explore Active Surveillance Mode of the Community's Adverse Event Following Immunization(AEFI) — AEFI  

Adverse Reaction to Drug Clinical Trial

Official title:
Phase 4 Study of MR and APDT Vaccine

Clinical Trial Summary

The investigators would remind the guardians of observation after immunization via sending short message and collect the information of AEFI by two ways, short message/telephone and website questionnaire.

Clinical Trial Description

The investigators will compare the rate between active and inactive surveillance of AEFI ;

Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01830257
Study type Interventional
Source Beijing Center for Disease Control and Prevention
Contact
Status Enrolling by invitation
Phase Phase 4
Start date April 2013
Completion date June 2014
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT01430702 - Feasibility of Using a Telemedicine Medication Delivery Unit for Older Adults N/A
Active, not recruiting NCT01237275 - Development of A Technique to Predict Antidepressant Responsiveness in Depressive Patients N/A
Terminated NCT02296840 - Post-operative Pain Control After Pediatric Adenotonsillectomy Phase 4
Terminated NCT01600677 - Determining the Impact of a Medication Delivery Unit on Medication Adherence of Adults With Common Cardiac Conditions N/A
Recruiting NCT02353455 - Cells of Monocytic Origin as Surrogate Markers for Individual Drug Effects and Hepatotoxicity
Completed NCT02012712 - Personal Health Records and Elder Medication Use Quality N/A
Completed NCT02609919 - Assessment of Immediate Adverse Reactions From Dotarem in Children Under 2 Years of Age
Completed NCT06124417 - Efficacy and Safety of Sertraline in the Treatment of Maintenance Hemodialysis Patients With Depression Phase 4
Recruiting NCT00817375 - Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients N/A
Active, not recruiting NCT00935246 - Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning N/A
Completed NCT04226443 - The Use of Midazolam and Remifentanil During Dialysis Access Procedures N/A
Recruiting NCT02520570 - Post-market Safety Reassessment of Ulinastatin for Injection
Completed NCT01621373 - Exploratory Propofol Dose Finding Study In Neonates Phase 2
Completed NCT02447679 - Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence Phase 2
Recruiting NCT05645302 - Intensive Monitoring Scheme of Lidocaine Cataplasms
Recruiting NCT01354197 - The Thai Surgical Intensive Care Study (Thai-SICU Study) N/A
Recruiting NCT04655794 - Clinical Analysis of Safety in Latent Tuberculosis Infection Prophylaxis Treatment